Added value of drug-laboratory test interaction alerts in test result authorisation

Jasmijn A. Van Balveren*, Wilhelmine P.H.G. Verboeket-Van De Venne, Carine J.M. Doggen, Lale Erdem-Eraslan, Albert J. De Graaf, Johannes G. Krabbe, Ruben E.A. Musson, Wytze P. Oosterhuis, Yolanda B. De Rijke, Heleen Van Der Sijs, Andrei N. Tintu, Rolf J. Verheul, Rein M.J. Hoedemakers, Ron Kusters

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)E108-E111
JournalClinical Chemistry and Laboratory Medicine
Volume60
Issue number5
Early online date18 Feb 2022
DOIs
Publication statusPublished - 26 Apr 2022

Keywords

  • clinical decision support system (CDSS)
  • diagnostic error
  • drug-laboratory test interaction (DLTI)
  • laboratory test
  • patient safety

Cite this